Abstract
The 1990 Clean Air Act mandated oxygenation of gasoline in regions where carbon monoxide standards were not met. To achieve this standard, methyl tertiary butyl ether (MTBE) was increased to 15% by volume during winter months in many locations. Subsequent to the increase of MTBE in gasoline, commuters reported increases in symptoms such as headache, nausea, and eye, nose, and throat irritation. The present study compared 12 individuals selected based on self-report of symptoms (self-reported sensitives; SRSs) associated with MTBE to 19 controls without self-reported sensitivities. In a double-blind, repeated measures, controlled exposure, subjects were exposed for 15 min to clean air, gasoline, gasoline with 11% MTBE, and gasoline with 15% MTBE. Symptoms, odor ratings, neurobehavioral performance on a task of driving simulation, and psychophysiologic responses (heart and respiration rate, end-tidal CO(2), finger pulse volume, electromyograph, finger temperature) were measured before, during, and immediately after exposure. Relative to controls, SRSs reported significantly more total symptoms when exposed to gasoline with 15% MTBE than when exposed to gasoline with 11% MTBE or to clean air. However, these differences in symptoms were not accompanied by significant differences in neurobehavioral performance or psychophysiologic responses. No significant differences in symptoms or neurobehavioral or psychophysiologic responses were observed when exposure to gasoline with 11% MTBE was compared to clean air or to gasoline. Thus, the present study, although showing increased total symptoms among SRSs when exposed to gasoline with 15% MTBE, did not support a dose-response relationship for MTBE exposure nor the symptom specificity associated with MTBE in epidemiologic studies.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alaoui-Ismaïli O., Robin O., Rada H., Dittmar A., Vernet-Maury E. Basic emotions evoked by odorants: comparison between autonomic responses and self-evaluation. Physiol Behav. 1997 Oct;62(4):713–720. doi: 10.1016/s0031-9384(97)90016-0. [DOI] [PubMed] [Google Scholar]
- Alaoui-Ismaïli O., Vernet-Maury E., Dittmar A., Delhomme G., Chanel J. Odor hedonics: connection with emotional response estimated by autonomic parameters. Chem Senses. 1997 Jun;22(3):237–248. doi: 10.1093/chemse/22.3.237. [DOI] [PubMed] [Google Scholar]
- Dalton P., Wysocki C. J., Brody M. J., Lawley H. J. Perceived odor, irritation, and health symptoms following short-term exposure to acetone. Am J Ind Med. 1997 May;31(5):558–569. doi: 10.1002/(sici)1097-0274(199705)31:5<558::aid-ajim10>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- Green B. G., Dalton P., Cowart B., Shaffer G., Rankin K., Higgins J. Evaluating the 'Labeled Magnitude Scale' for measuring sensations of taste and smell. Chem Senses. 1996 Jun;21(3):323–334. doi: 10.1093/chemse/21.3.323. [DOI] [PubMed] [Google Scholar]
- Hoffmann U., Essfeld D., Stegemann J. Comparison of arterial, end-tidal and transcutaneous PCO2 during moderate exercise and external CO2 loading in humans. Eur J Appl Physiol Occup Physiol. 1990;61(1-2):1–4. doi: 10.1007/BF00236685. [DOI] [PubMed] [Google Scholar]
- Hudnell H. K., Otto D. A., House D. E., Mølhave L. Exposure of humans to a volatile organic mixture. II. Sensory. Arch Environ Health. 1992 Jan-Feb;47(1):31–38. doi: 10.1080/00039896.1992.9935941. [DOI] [PubMed] [Google Scholar]
- Kavanagh B. P., Sandler A. N., Turner K. E., Wick V., Lawson S. Use of end-tidal PCO2 and transcutaneous PCO2 as noninvasive measurement of arterial PCO2 in extubated patients recovering from general anesthesia. J Clin Monit. 1992 Jul;8(3):226–230. doi: 10.1007/BF01616780. [DOI] [PubMed] [Google Scholar]
- Lorig T. S. Human EEG and odor response. Prog Neurobiol. 1989;33(5-6):387–398. doi: 10.1016/0301-0082(89)90007-5. [DOI] [PubMed] [Google Scholar]
- Mills K. C., Parkman K. M., Spruill S. E. A PC-based software test for measuring alcohol and drug effects in human subjects. Alcohol Clin Exp Res. 1996 Dec;20(9):1582–1591. doi: 10.1111/j.1530-0277.1996.tb01703.x. [DOI] [PubMed] [Google Scholar]
- Moolenaar R. L., Hefflin B. J., Ashley D. L., Middaugh J. P., Etzel R. A. Methyl tertiary butyl ether in human blood after exposure to oxygenated fuel in Fairbanks, Alaska. Arch Environ Health. 1994 Sep-Oct;49(5):402–409. doi: 10.1080/00039896.1994.9954993. [DOI] [PubMed] [Google Scholar]
- Nihlén A., Wâlinder R., Löf A., Johanson G. Experimental exposure to methyl tertiary-butyl ether. II. Acute effects in humans. Toxicol Appl Pharmacol. 1998 Feb;148(2):281–287. doi: 10.1006/taap.1997.8342. [DOI] [PubMed] [Google Scholar]
- Prah J. D. 1998 equivalence of sensory responses to single and mixed volatile organic compounds at equimolar concentrations. Environ Health Perspect. 1998 Nov;106(11):739–744. doi: 10.1289/ehp.98106739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robin O., Alaoui-Ismaïli O., Dittmar A., Vernet-Maury E. Emotional responses evoked by dental odors: an evaluation from autonomic parameters. J Dent Res. 1998 Aug;77(8):1638–1646. doi: 10.1177/00220345980770081201. [DOI] [PubMed] [Google Scholar]
- White M. C., Johnson C. A., Ashley D. L., Buchta T. M., Pelletier D. J. Exposure to methyl tertiary-butyl ether from oxygenated gasoline in Stamford, Connecticut. Arch Environ Health. 1995 May-Jun;50(3):183–189. doi: 10.1080/00039896.1995.9940385. [DOI] [PubMed] [Google Scholar]